STOCK TITAN

Repsly Announces New Retail Technology Partnership with Curaleaf

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
partnership
Rhea-AI Summary

Curaleaf (CSE: CURA / OTCQX: CURLF), a leading cannabis provider, has partnered with Repsly, a retail technology platform, to enhance its wholesale operations across the U.S. This collaboration, announced on February 2, 2022, aims to leverage Repsly's CRM solutions, retail execution support, and business analytics. With 125 dispensaries in 23 states, Curaleaf will utilize Repsly's Insights Dashboard to improve sales performance and adapt strategies based on real-time data. The rollout of the Repsly platform will commence in February 2022.

Positive
  • Partnership with Repsly enhances Curaleaf's technology stack.
  • Use of CRM and analytics solutions aimed at improving wholesale operations.
  • Real-time data access will improve sales performance and adaptability.
Negative
  • None.

BOSTON, Feb. 2, 2022 /PRNewswire/ -- Repsly, a best-in-class retail technology platform, today announced it has entered into a technology partnership agreement with Curaleaf (CSE: CURA / OTCQX: CURLF), a leading international provider of consumer products in cannabis. This agreement will support Curaleaf's wholesale operations across the US by providing CRM solutions, retail execution support, and business analytics and insights to the Curaleaf teams.

The retail technology platform will provide CRM, retail execution and business analytics solutions.

With 125 dispensaries in 23 U.S. states, Curaleaf is one of the largest vertically integrated cannabis companies. Curaleaf chose Repsly after realizing a need to enhance their technology stack in support of their quickly expanding go-to-market needs within North America.

"With Repsly's powerful operational platform and their Insights Dashboard business intelligence solution, we'll be able to assess our wholesale execution plans with real-time and trended data on sales performance, promotion execution and more. These data-driven insights will allow our team to learn and pivot on a dime as feedback comes in from their field," said Patrick Larkin, SVP of Sales at Curaleaf.

"Our team at Repsly is obsessed with helping our customers win by executing perfectly at all aspects of retail, every day," said Matthew Brogie, CEO at Repsly. "Knowing that we have the opportunity to help Curaleaf navigate competitively in one of the fastest growing consumer industries, and that we can support Curaleaf and their portfolio of brands in their next generation plans is extremely energizing for our team! We're looking forward to rolling up our sleeves and working hard to demonstrate that Repsly is the right partner to support Curaleaf in this amazing growth journey."

Curaleaf will begin to roll out the Repsly platform in February 2022.

About Repsly
Repsly, Inc. is a retail execution software that empowers CPG teams to make data-driven insights and achieve peak performance in the field. Repsly helps global brands like Kraft Heinz, Adidas, L'Oreal, Spindrift, Beyond Meat, Mattel, and AB InBev control compliance at the brand level, improve coverage at the territory level, and execute at the store level. Repsly is the only retail execution solution to connect store-level activities with their impact on sales. Headquartered in Boston, MA with offices globally, Repsly works with over 800 brands in 80 countries around the world.

About Curaleaf
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf currently operates in 23 states with 125 dispensaries, 25 cultivation sites, and employs over 5,200 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.

Media enquiries to:
Cait Will (cait.will@repsly.com)
Stephanie Pojatina (stephanie.pojatina@repsly.com)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/repsly-announces-new-retail-technology-partnership-with-curaleaf-301473778.html

SOURCE Repsly Inc.

FAQ

What is the purpose of Curaleaf's partnership with Repsly?

The partnership aims to enhance Curaleaf's wholesale operations through CRM solutions, retail execution support, and business analytics.

When will Curaleaf start using the Repsly platform?

Curaleaf is set to roll out the Repsly platform in February 2022.

How many dispensaries does Curaleaf operate?

Curaleaf operates 125 dispensaries across 23 U.S. states.

What type of insights will Curaleaf gain from the Repsly partnership?

Curaleaf will gain access to real-time data on sales performance and promotion execution from the Repsly Insights Dashboard.

CURALEAF HLDGS INC

OTC:CURLF

CURLF Rankings

CURLF Latest News

CURLF Stock Data

1.67B
411.16M
29.87%
1.36%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
New York